Melanotan II dosage advice on TikTok: what the science says

What did @phoenixfitnesscoaching actually say?

The creator recommended Melanotan II (MT2) injections at "250 to 500 micrograms" per dose, timed before sun exposure or sunbed use. They also argued injections are "more effective than the nasal sprays" because of superior bioavailability, and warned against overuse to avoid what they called the "dirty face look" side effect.

To be clear about what we're dealing with here: Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It was originally developed at the University of Arizona in the 1980s as a potential tanning agent and later explored for erectile dysfunction. It has never been approved by the FDA, the MHRA, or any major regulatory body for any use. Buying or selling it as a consumer product is illegal in many jurisdictions, including the UK. That context matters enormously before anyone starts talking dosing ranges like this is a supplement stack conversation.

Does the science back this up?

The bioavailability argument is generally correct, but the framing glosses over the real risks. Subcutaneous injection does produce more predictable systemic absorption than intranasal delivery, but that increased absorption is also why injection carries a higher adverse event burden.

The dose range cited, 250 to 500 micrograms, falls within what has appeared in early clinical research. Dorr et al. (2004, Journal of Investigative Dermatology) used doses in a similar range in a controlled setting and documented significant side effects including nausea, facial flushing, and spontaneous erections even at lower doses. A later review by Langan et al. (2017, British Journal of Dermatology) noted that unregulated MT2 use is associated with atypical mole development and a documented link to melanoma risk. The "dirty face look" the creator mentions is almost certainly referring to accelerated or uneven melanocyte stimulation, which in clinical literature is flagged as a potential marker of dysplastic nevus activity, not just a cosmetic nuisance.

What did they get wrong (or right)?

Credit where it's due: the bioavailability point is scientifically reasonable. Intranasal peptide delivery is genuinely less reliable than subcutaneous injection for most compounds, and MT2 is no exception. The creator is not wrong on the pharmacology there.

What they got wrong, or at least dangerously incomplete, is the risk framing. Describing melanoma-adjacent side effects as a "dirty face look" you just want to avoid aesthetically is a significant misrepresentation of what's actually happening physiologically. The creator presents no context about contraindications, no mention that people with pre-existing nevi or a family history of melanoma face compounded risk, and no acknowledgment that MT2 is unregulated and not subject to quality control. Compounded or gray-market MT2 has no guaranteed purity, no standardized concentration, and no oversight. Studies on illicitly sourced peptides, including Brennan et al. (2018, Drug Testing and Analysis), have found contamination and mislabeling in a meaningful percentage of samples tested. Framing a dosing window for this compound as casual fitness advice is a stretch that responsible coaching should not make.

What should you actually know?

Melanotan II is not a tanning supplement in any regulated or approved sense. It is a research peptide with a real pharmacological mechanism and a real adverse event profile that goes well beyond cosmetic side effects.

The documented risks include nausea and vomiting (particularly at doses above 250 mcg), spontaneous and prolonged erections in men, changes to existing moles and potential promotion of melanocytic activity, and cardiovascular effects including blood pressure changes. A case series published by Ting et al. (2010, Journal of the American Academy of Dermatology) documented multiple patients developing changing moles and one confirmed melanoma in the context of MT2 use. That is not a minor footnote.

If you are interested in skin health or sun protection, there are evidence-based, legally available options. Using MT2 based on a TikTok dosing guide, regardless of how confident the creator sounds, is a decision made without the clinical oversight this compound genuinely requires.

• MT2 is not approved by the FDA, MHRA, or any comparable body for cosmetic or therapeutic use.
• Unregulated sources carry contamination and mislabeling risks that make any dosing advice speculative at best.
• The "dirty face" side effect the creator references reflects real changes in melanocyte behavior, not just an aesthetic issue.
• Anyone with a history of atypical moles, melanoma, or strong family history of skin cancer faces particularly elevated risk.